Clinical Trial Update: A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments for Adult Patients With Multiple Myeloma That is Resistant to Current Standard of Care Treatments [Phase 1]

View source ↗

Summary

Clinical trial update announcing a Phase 1 study of Linvoseltamab in combination with other cancer treatments for adults with multiple myeloma resistant to stan…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Linvoseltamab

Snippet

Sponsor: Regeneron Pharmaceuticals | Conditions: Multiple Myeloma | Phase 1 | Status: RECRUITING